Helius Medical Technologies Inc (HSDT)
2.86
+0.20
(+7.52%)
USD |
NASDAQ |
May 03, 16:00
2.71
-0.15
(-5.24%)
After-Hours: 20:00
Helius Medical Technologies Profit Margin (Quarterly): -779.9% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -779.9% |
September 30, 2023 | -2.56K% |
June 30, 2023 | -643.8% |
March 31, 2023 | -2.25K% |
December 31, 2022 | -1.73K% |
September 30, 2022 | -525.5% |
June 30, 2022 | -3.20K% |
March 31, 2022 | -2.29K% |
December 31, 2021 | -1.59K% |
September 30, 2021 | -4.30K% |
June 30, 2021 | -8.42K% |
Date | Value |
---|---|
March 31, 2021 | -4.00K% |
December 31, 2020 | -1.33K% |
September 30, 2020 | -2.65K% |
June 30, 2020 | -2.53K% |
March 31, 2020 | -2.30K% |
December 31, 2019 | -3.51K% |
September 30, 2019 | -3.73K% |
June 30, 2019 | -35.91% |
March 31, 2019 | |
December 31, 2018 | -1.07K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-8.42K%
Minimum
Jun 2021
-35.91%
Maximum
Jun 2019
-2.55K%
Average
-2.30K%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
ARCA biopharma Inc | -- |
Cerus Corp | -2.84% |
NeuroOne Medical Technologies Corp | -342.1% |
Perspective Therapeutics Inc | -- |
Electromed Inc | 12.23% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -183.1% |
Return on Assets | -75.85% |
Return on Invested Capital | -183.1% |
Gross Profit Margin (Quarterly) | 32.84% |
Operating Margin (Quarterly) | -1.68K% |
Return on Net Operating Assets | -412.4% |